AUTHORS
Bret Jensen
With over 20 years of experience in the financial industry, Bret Jensen brings success as an investor and entrepreneur to TheStreet Real Money Pro team. As the chief investment strategist at Simplified Asset Management between 2008-2011, Jensen’s small long/short hedge fund was in the top 5% of long/short hedge funds for total return in its first full year (2009) as ranked by Hedgeco fund database. He currently acts as corporate secretary for Florida Alternative Investment Association, which encompasses more than 100 managers managing more than $30 billion in assets under management.
Jensen specializes in value and GARP investing, along with simple options strategies like covered call trades. He is passionate about teaching others how to achieve financial independence at a relatively young age like he did.
He has been a Real Money and Real Money Pro contributor for TheStreet team since 2012. His coverage focuses primarily on sector coverage, stock trading ideas, options trading, and macroeconomic trends. Fun fact about Jensen: he became a professional poker player at the age of 18 before turning his attention to investing.
Recent Articles By The Author
Here Are My 2 Latest Stock Plays in This Alfred E. Neuman Market
While the music is still playing, I continue to make small incremental bets on down days.
My 'Druckenmiller' Investing Game Plan: 3 Ways of Adjusting to the New Reality
Here is how I plan to play a sideways market should the hedge fund manager's views turn out to be prescient.
Lasso in an Opportunity With a Lone Star Bank
I'm making a bet on Texas with this well-run bargain.
'70s Redux? I'm in Druckenmiller's Camp, But Not Ready to Accept a 'Lost Decade'
It is eerie how this economic and political environment seems more and more like a previous era.
The Credit Crunch Is Certain to Push the Economy Into Recession
The banking system is going to have to pull back on lending, especially on the regional level.
Playing It Safe by Hiding Out In Yield Plays
Here's my strategy right now, including a 'no-brainer' move, and three individual plays.
I'm Worried About the Yield Curve and You Should Be Too
'Sell in May and Go Away' is likely to loom large this year.
These Biotech Names Could Be the Next Logical Buyout Targets
Nothing sparks the animal spirits in the biotech sector like a significant acquisition.
The Nasdaq Looks Overdue for a Pullback
Here's the trigger that could cause the index to give back a decent portion of its gains in 2023.
Oops!
We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.
Please Join or Log In to Email Our Authors.
Email Real Money's Wall Street Pros for further analysis and insight
Already a Subscriber? Login